A urine biomarker for severe obstructive sleep apnoea patients: lipocalin-type prostaglandin D synthase Source: Eur Respir J 2013; 42: 1563-1574 Year: 2013
Evaluation of 8-isoprostane as a biomarker of oxidative stress in children with obstructive sleep apnea syndrome Source: Annual Congress 2012 - Sleep monitoring, lung function and inflammation in childhood Year: 2012
Heat shock proteins, L-arginine, and asymmetric dimethylarginine levels in patients with obstructive sleep apnea syndrome Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing Year: 2015
Renin and aldosterone levels in obstructive sleep apnea syndrome patients Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing Year: 2015
S100B protein: A useful marker in obstructive sleep apnea syndrome Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology Year: 2012
Obesity and severity of nocturnal desaturations have synergestic effects on the increased urinary excretion of leukotriene E4 in sleep apnea syndrome Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008
5-lipoxygenase pathway: one of the mediators of early atherosclerosis in obstructive sleep apnea syndrome? Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007
Interrelationships between oxidative stress and MMP-9 in subjects with severe obstructive sleep apnea syndrome Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea Year: 2016
Relationship between obstructive sleep apnea syndrome, plasma homocysteine levels and cardiovascular risk Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing Year: 2013
C-reactive protein levels in obstructive sleep apnea syndrome Source: Eur Respir J 2005; 26: Suppl. 49, 356s Year: 2005
Serum gamma-glutamyl transferase activity: A new prognostic factor in obstructive sleep apnea syndrome? Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea Year: 2010
Plasma homocysteine (Hcy) levels in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2007 - Cardiovascular and respiratory control in obstructive sleep apnoea Year: 2007
Nitric oxide and obstructive sleep apnea syndrome (OSAS): reflection of inflammation and oxidative stress Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008
Serum midkine levels in patients with obstructive sleep apnea Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing Year: 2015
Overnight urinary isoprostanes as a marker of oxidative stress in obstructive sleep apnoea Source: Eur Respir J , 49 (2) 1601787; DOI: 10.1183/13993003.01787-2016 Year: 2017
Elevated serum homocysteine levels in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 566s Year: 2004
8-isoprostanes and resistin as markers of vascular damage in non-hypersomnolent obstructive sleep apnea patients Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels Year: 2016
Exhaled nitric oxide is not altered in patients with obstructive sleep apnea syndrome Source: Annual Congress 2007 - Airway regulation, provocation and monitoring II Year: 2007
Urine albumin excretion (UAE) is predictive of subclinical cardiovascular diseases associated with obstructive sleep apnea syndrome (OSA) Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007
Endothelial and systemic inflammation in obstructive sleep apnea syndrome: Impact of CPAP therapy on CRP plasma levels Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea Year: 2010